Greenwave Technology Solutions, Inc. (GWAV): Nasdaq/NYSE listing notice — Greenwave receives Nasdaq deficiency notice for bid price below $1.00

Greenwave Technology Solutions, Inc.

Received Nasdaq Staff Deficiency Letter on May 17, 2023 for non-compliance with minimum bid price rule.
Bid price closed below $1.00 for 30 consecutive business days; 180-day cure period ends Nov 13, 2023.
To regain compliance, stock must close at $1.00+ for at least 10 consecutive business days.
Company may consider a reverse stock split or other options if unable to cure by deadline.
No immediate impact on listing or trading of GWAV common stock.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.99

Greenwave Technology Solutions, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

May 17, 2023, Greenwave Technology Solutions, Inc. (the “Company”) received a letter (the “Nasdaq Staff Deficiency Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, for the last thirty (30) consecutive business days, the bid price for the Company’s common stock had closed below the minimum $1.00 per share requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided an initial period of 180 calendar days, or until November 13, 2023, to regain compliance

View on SEC.gov

Browse all listing & compliance notices →

Greenwave Technology Solutions, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-018528

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.